Inventor · West Chester, PA, US

Jay Theroff

17Patents

8h-index

55Co-inventors

71Inventor score

Filing activity: Apr 30, 2007 → Apr 25, 2022

Most-cited inventions

Patent	Title	Area	Cited by	Status
US7601716B2	Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors	Human Necessities	22	Active
US9809588B2	GLS1 inhibitors for treating disease	Chemistry; Metallurgy	15	Active
US10344025B2	GLS1 inhibitors for treating disease	Chemistry; Metallurgy	12	Active
US8148391B2	Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitors	Chemistry; Metallurgy	11	Active
US8552186B2	Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors	Chemistry; Metallurgy	9	Active
US10766892B2	GLS1 inhibitors for treating disease	Chemistry; Metallurgy	9	Active
US8080561B2	Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors	Human Necessities	8	Active
US7919502B2	Pyridopyrazines and derivatives thereof as ALK and c-MET inhibitors	Human Necessities	8	Active
US9018380B2	Heterocyclic modulators of HIF activity for treatment of disease	Chemistry; Metallurgy	7	Active
US11370786B2	GLS1 inhibitors for treating disease	Chemistry; Metallurgy	6	Active
US9481692B2	Heterocyclic modulators of HIF activity for treatment of disease	Chemistry; Metallurgy	4	Active
US11958849B2	GLS1 inhibitors for treating disease	Chemistry; Metallurgy	2	Active
US10208059B2	Heterocyclic modulators of HIF activity for treatment of disease	Chemistry; Metallurgy	1	Active
US8471005B2	Pyrrolotriazines as ALK and JAK2 inhibitors	Human Necessities	1	Active
US11365189B2	Heterocyclic inhibitors of tyrosine kinase	Chemistry; Metallurgy	0	Active
US9475766B2	Substituted aromatic sulfur compounds and methods of their use	Chemistry; Metallurgy	0	Active
US11001594B2	Heterocyclic modulators of HIF activity for treatment of disease	Chemistry; Metallurgy	0	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.